|
| Michael J Trnka | Department of Pharmaceutical Chemistry, University of California San Francisco |
| Riccardo Pellarin | Institut Pasteur, CNRS UMR 8, C3BI USR 3756 CNRS & IP |
| Philip J Robinson | Birkbeck University of London, Institute of Structural and Molecular Biology |